Huge Pelvic GIST Got Good Control after Resistance to Tyrosine Kinase Inhibitors by SIB-IMRT: A Case Report and a Review of Literature — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Huge Pelvic GIST Got Good Control after Resistance to Tyrosine Kinase Inhibitors by SIB-IMRT: A Case Report and a Review of Literature
Department of Gynecological Oncology, Chongqing University Cancer Hospital, Chongqing, China
,
Department of Oncology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
1 Department of Gynecological Oncology, Chongqing University Cancer Hospital, Chongqing, China
2 Department of Oncology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
Purpose : Gastrointestinal stromal tumor (GIST) has been considered radiation-resistant and data on the radiotherapy for GIST in previous studies are lacking. The purpose of this article is to accumulate more experience in the application of radiotherapy for GISTs. Materials an d methods: Review our own case material and the relevant English literature. Results : A huge pelvic GIST after resistance to tyrosine kinase inhibitors (TKIs) has been well controlled by simultaneous-integrated boost intensity-modulated radiation therapy (SIB-IMRT). The time from the initial shrinkage of the mass and subsequent stabilization to now was more than 18 months. The patient was palliated from the series of symptoms caused by tumor compression and well tolerated to the adverse reactions by radiotherapy. And the previous studies have shown that GISTs had a certain sensitivity to radiotherapy. Conclusion: SIB-IMRT may provide a new means of achieving objective response and prolonging survival in selected GIST patients.
Aznab, M. and Akhmadi, S.M. (2018) Long-Term Results of Adjuvant Imatinib Treatment for Localized Gastrointestinal Stromal Tumors after Surgery. Asian Pacific Journal of Cancer Prevention , 19, 39-43.
Demetri, G.D., von Mehren, M., Antonescu, C.R., DeMatteo, R.P., Ganjoo, K.N., Maki, R.G., et al . (2010) NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors. Journal of the National Comprehensive Cancer Network , 8, S-1-S-41. https://doi.org/10.6004/jnccn.2010.0116
Ihle, M.A., Huss, S., Jeske, W., Hartmann, W., Merkelbach-Bruse, S., Schildhaus, H., et al . (2018) Expression of Cell Cycle Regulators and Frequency of TP53 Mutations in High Risk Gastrointestinal Stromal Tumors Prior to Adjuvant Imatinib Treatment. PLOS ONE , 13, e0193048. https://doi.org/10.1371/journal.pone.0193048
Efared, B., Atsame-Ebang, G., Tahiri, L., Sidibé, I.S., Erregad, F., Hammas, N., et al . (2018) The Expression of MDM2 in Gastrointestinal Stromal Tumors: Immunohistochemical Analysis of 35 Cases. BMC Clinical Pathology , 18, Article No. 2. https://doi.org/10.1186/s12907-018-0069-0
Moodley, J., Cutz, J. and Schell, M. (2018) Reactive Nodular Fibrous Pseudotumor Mimicking Metastatic Gastrointestinal Stromal Tumor to Perigastric Lymph Node: A Case Report and Review of the Literature. International Journal of Surgical Pathology , 26, 664-670. https://doi.org/10.1177/1066896918771192
Li, J., Ye, Y., Wang, J., Zhang, B., Qin, S., Shi, Y., et al . (2017) Chinese Consensus Guidelines for Diagnosis and Management of Gastrointestinal Stromal Tumor. Chinese Journal of Cancer Research , 29, 281-293. https://doi.org/10.21147/j.issn.1000-9604.2017.04.01
Shen, C., Chen, H., Yin, Y., Chen, J., Zhang, B., Chen, Z., et al . (2014) Preoperative Imatinib for Patients with Primary Unresectable or Metastatic/Recurrent Gastrointestinal Stromal Tumor. Clinics , 69, 758-762. https://doi.org/10.6061/clinics/2014(11)09
Lim, K.T. (2017) Surgical Treatment of Gastrointestinal Stromal Tumors of the Stomach: Current Status and Future Perspective. Translational Gastroenterology and Hepatology , 2, 104-104. https://doi.org/10.21037/tgh.2017.12.01
Montemurro, M., Cioffi, A., Dômont, J., Rutkowski, P., Roth, A.D., von Moos, R., et al . (2018) Long-Term Outcome of Dasatinib First-Line Treatment in Gastrointestinal Stromal Tumor: A Multicenter, 2-Stage Phase 2 Trial (Swiss Group for Clinical Cancer Research 56/07). Cancer , 124, 1449-1454. https://doi.org/10.1002/cncr.31234
Kasireddy, V. and von Mehren, M. (2017) Emerging Drugs for the Treatment of Gastrointestinal Stromal Tumour. Expert Opinion on Emerging Drugs , 22, 317-329. https://doi.org/10.1080/14728214.2017.1411479
Rutkowski, P., Jagielska, B., Andrzejuk, J., Bylina, E., Lugowska, I., Switaj, T., et al . (2017) The Analysis of the Long-Term Outcomes of Sorafenib Therapy in Routine Practice in Imatinib and Sunitinib Resistant Gastrointestinal Stromal Tumors (Gist). Współczesna Onkologia , 21, 285-289. https://doi.org/10.5114/wo.2017.72393
Röper, B., Heinrich, C., Kehl, V., Rechl, H., Specht, K., Wörtler, K., et al . (2015) Study of Preoperative Radiotherapy for Sarcomas of the Extremities with Intensity-Modulation, Image-Guidance and Small Safety-Margins (PREMISS). BMC Cancer , 15, Article No. 904. https://doi.org/10.1186/s12885-015-1633-y
Wang, D., Zhang, Q., Eisenberg, B.L., Kane, J.M., Li, X.A., Lucas, D., et al . (2015) Significant Reduction of Late Toxicities in Patients with Extremity Sarcoma Treated with Image-Guided Radiation Therapy to a Reduced Target Volume: Results of Radiation Therapy Oncology Group RTOG-0630 Trial. Journal of Clinical Oncology , 33, 2231-2238. https://doi.org/10.1200/jco.2014.58.5828
Lolli, C., Pantaleo, M.A., Nannini, M., Saponara, M., Pallotti, M.C., Di Scioscio, V., et al . (2011) Successful Radiotherapy for Local Control of Progressively Increasing Metastasis of Gastrointestinal Stromal Tumor. Rare Tumors , 3, 153-154. https://doi.org/10.4081/rt.2011.e49
de Moura, L.R., Marshall, J., Di Cesare, S., Fernandes, B.F., Antecka, E. and Burnier, M.N. (2012) The Effect of Imatinib Mesylate on the Proliferation, Invasive Ability, and Radiosensitivity of Retinoblastoma Cell Lines. Eye , 27, 92-99. https://doi.org/10.1038/eye.2012.231
Ozkan, E.E. (2018) Radiotherapy for Gastrointestinal Stromal Tumors. Chinese Med ical Journal , 131, 235-240. https://doi.org/10.4103/0366-6999.222344
Cuaron, J.J., Goodman, K.A., Lee, N. and Wu, A.J. (2013) External Beam Radiation Therapy for Locally Advanced and Metastatic Gastrointestinal Stromal Tumors. Radiation Oncology , 8, Article No. 274. https://doi.org/10.1186/1748-717x-8-274
Huang, W.L., Long, Q., Lu, W.L., Jiang, Q.F., Tan, B.X., Tian, L.J., Luo, Y., Xiao, Y. and Fang, W.J. (2016) Clinical Effects of IMRT and Simultaneous Integrated Boost-Intensity Modulated Radiation Therapy: A Comparative Study of 277 Patients with Advanced Cervical Cancer. International Journal of Radiation Medicine and Nu-clear Medicine , 40, 429-434.
Aparicio, T., Boige, V., Sabourin, J.-., Crenn, P., Ducreux, M., Le Cesne, A., et al . (2004) Prognostic Factors after Surgery of Primary Resectable Gastrointestinal Stromal Tumours. European Journal of Surgical Oncology ( EJSO ), 30, 1098-1103. https://doi.org/10.1016/j.ejso.2004.06.016
Crosby, J.A., Catton, C.N., Davis, A., Couture, J., O’Sullivan, B., Kandel, R., et al . (2001) Malignant Gastrointestinal Stromal Tumors of the Small Intestine: A Review of 50 Cases from a Prospective Database. Annals of Surgical Oncology , 8, 50-59. https://doi.org/10.1007/s10434-001-0050-4
Boruban, C., Sencan, O., Akmansu, M., Atik, E.T. and Ozbek, S. (2007) Metastatic Gastrointestinal Stromal Tumor with Long-Term Response after Treatment with Concomitant Radiotherapy and Imatinib Mesylate. Anti - Cancer Drugs , 18, 969-972. https://doi.org/10.1097/cad.0b013e3280e94982
Gatto, L., Nannini, M., Saponara, M., Di Scioscio, V., Beltramo, G., Frezza, G.P., et al . (2017) Radiotherapy in the Management of Gist: State of the Art and New Potential Scenarios. Clinical Sarcoma Research , 7, Article No. 1. https://doi.org/10.1186/s13569-016-0065-z
Pollock, J., Morgan, D., Denobile, J. and Williams, J. (2001) CASE REPORT: Adjuvant Radiotherapy for Gastrointestinal Stromal Tumor of the Rectum. Digestive Diseases and Sciences , 46, 268-272. https://doi.org/10.1023/a:1005581000712